Boy to travel to US to have heart transplant surgeryMainichi Daily NewsTOKYO (Kyodo) — A 13-year-old Japanese boy suffering from serious dilated cardiomyopathy will travel to the United States on Thursday to have a heart transplant surgery, members of…
New Drug Shows Promise for Myeloma Patients
WEDNESDAY, May 9 (HealthDay News) — Three new studies confirm that the drug lenalidomide can significantly lengthen the time that people with multiple myeloma experience no worsening of their disease, either after having a stem cell transplant or gett…
Lenalidomide shows significant benefit for myeloma patients, phase III study suggests
Medical researchers report significant time-to-progression benefit as well as survival benefit for patients who took maintenance doses of lenalidomide following stem-cell transplant.
Gene-modified stem cell transplant protects patients from toxic side effects of chemotherapy, study suggests
For the first time, scientists have transplanted brain cancer patients' own gene-modified blood stem cells in order to protect their bone marrow against the toxic side effects of chemotherapy. Initial results of the ongoing, small clinical trial of…
Gene-Modified Stem Cell Transplant Protects Patients from Toxic Side Effects … – Science Daily (press release)
Gene-Modified Stem Cell Transplant Protects Patients from Toxic Side Effects …Science Daily (press release)As many as 50 percent to 60 percent of glioblastoma patients harbor such chemotherapy-resistant tumors, which makes gene-modified stem cell tra…
2 Calif. cops face trial over beating death of homeless man – USA TODAY
USA TODAY2 Calif. cops face trial over beating death of homeless manUSA TODAYHospital records showed that Thomas suffered brain injuries, a shattered nose, a smashed cheekbone, broken ribs and severe internal bleeding. The coroner said he died of brain…
Study Indicates Stem Cell Shield Could Potentially Protect Cancer Patients – Daily Disruption
Study Indicates Stem Cell Shield Could Potentially Protect Cancer PatientsDaily DisruptionAs many as 50 percent to 60 percent of glioblastoma patients harbor such chemotherapy-resistant tumors, which makes gene-modified stem cell transplant therapy app…
Growing cases of kids swallowing potentially fatal magnets
Melanie Hebert / Eyewitness News Email: mhebert@wwltv.com | Twitter: @melaniehebert NEW ORLEANS — Braylon Jordan is recovering from a near-fatal experience after swallowing several pea-sized magnets. “It's been really, really difficult. You have…
RPCI Physician, Colleagues Publish Findings from Phase III Study on Lenalidomide Maintenance for Myeloma Patients
In article in New England Journal of Medicine, Dr. Philip L. McCarthy and co-authors report significant time-to-progression benefit as well as survival benefit for patients who took maintenance doses of lenalidomide following stem-cell transplant.
Vatican Radio tackles organ harvesting in light of questionable 'brain death … – Lifesite
LifesiteVatican Radio tackles organ harvesting in light of questionable 'brain death …Lifesiteby Thaddeus Baklinski ROME, May 9, 2012 (LifeSiteNews.com) – The controversy surrounding the questionable criterion of 'brain death' used to det…